Concepedia

Samuel E. Dalton

SE

Statistics

Publications

3

Citations

188

H-Index

3

Active since

2017

Affiliations

GlaxoSmithKline (Ireland)(Current)

University of Strathclyde

Samuel E. Dalton is an author at GlaxoSmithKline (Ireland) specializing in medicinal chemistry, pharmacology, and covalent inhibitor design.

Publications per year

2017–2022

3

Publications

3

Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition

Samuel E. Dalton, Lars Dittus, Daniel A. Thomas et al. · Journal of the American Chemical Society · 2017 · 114 citations

, , +17

Dual Roles for Potassium Hydride in Haloarene Reduction: CS<sub>N</sub>Ar and Single Electron Transfer Reduction via Organic Electron Donors Formed in Benzene

Joshua P. Barham, Samuel E. Dalton, Mark Allison et al. · Journal of the American Chemical Society · 2018 · 47 citations · Full text

, , +13

X-ray Screening of an Electrophilic Fragment Library and Application toward the Development of a Novel ERK 1/2 Covalent Inhibitor

Jeffrey D. St. Denis, Gianni Chessari, Anne Cleasby et al. · Journal of Medicinal Chemistry · 2022 · 27 citations · Full text

, , +16

1–3 of 3